Clinical Pharmacy Services in Ambulatory Oncology: An Environmental Scan of the Canadian Practice Landscape

dc.contributor.authorTibensky, Bryanna
dc.contributor.authorHutton, Lauren
dc.contributor.authorWentzell, Jason
dc.contributor.authorLeBlanc, Michael
dc.contributor.authorEdwards, Scott
dc.contributor.authorMcFarlane, Thomas
dc.date.accessioned2023-03-20T17:54:24Z
dc.date.available2023-03-20T17:54:24Z
dc.date.issued2023-02-21
dc.description.abstractBackground: Canadian clinical pharmacy key performance indicators (cpKPIs) have been developed for inpatient hospital practice but are not established for ambulatory oncology. This study represents the first step in developing cpKPIs for ambulatory oncology. Objectives: To describe the current landscape of pharmacy services in ambulatory oncology in Canada and to identify perspectives related to the development and implementation of cpKPIs in this practice setting. Methods: In this national cross-sectional study, a web-based questionnaire was distributed to pharmacists working in ambulatory oncology settings. Potential participants who self-identified as pharmacists practising in an ambulatory oncology setting were eligible. Survey questions focused on participants’ demographic characteristics, oncology pharmacy services provided, metrics captured, and pharmacists’ perceptions of cpKPIs. All data were analyzed using descriptive statistics. Results: A total of 44 responses were received, with most respondents practising in community hospitals in British Columbia, Ontario, and Atlantic Canada. The services most commonly provided were chemotherapy order verification, laboratory monitoring, identification and resolution of drug therapy problems, and counselling on anticancer medications. Twenty-six of the 44 respondents (59%) indicated that performance metrics or patient outcomes were tracked at their respective institutions, with none being universally captured. Overall, 43 (98%) of the respondents favoured the development of cpKPIs for ambulatory oncology practice. Conclusions: Despite growing patient care needs in ambulatory oncology, there is significant heterogeneity in the scope of pharmacy services offered and the outcomes used to qualify their impact within this setting across Canada. This study demonstrates a clear need for national consensus cpKPIs to inform pharmacy resource utilization and patient-centred quality improvement initiatives.en
dc.identifier.urihttp://hdl.handle.net/10012/19214
dc.language.isoenen
dc.publisherUniversity of Waterlooen
dc.subjectclinical pharmacy key performance indicatoren
dc.subjectambulatory oncologyen
dc.subjectoncology pharmacyen
dc.titleClinical Pharmacy Services in Ambulatory Oncology: An Environmental Scan of the Canadian Practice Landscapeen
dc.typeResidency Paperen
uws.contributor.affiliation1Faculty of Scienceen
uws.contributor.affiliation2School of Pharmacyen
uws.peerReviewStatusUnrevieweden
uws.published.cityWaterlooen
uws.published.countryCanadaen
uws.published.provinceOntarioen
uws.typeOfResourceTexten

Files

Original bundle

Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
Residency Research Report FINAL_Bryanna Tibensky.pdf
Size:
1.19 MB
Format:
Adobe Portable Document Format
Description:
Residency Paper
No Thumbnail Available
Name:
Emergency Naloxone Administration Policy - Draft v3.docx
Size:
27.72 KB
Format:
Microsoft Word XML
Description:
Loading...
Thumbnail Image
Name:
Naloxone at CFFM.pdf
Size:
954.5 KB
Format:
Adobe Portable Document Format
Description:
No Thumbnail Available
Name:
Naloxone Instructions for Emergency Kit.docx
Size:
202.43 KB
Format:
Microsoft Word XML
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.47 KB
Format:
Item-specific license agreed upon to submission
Description: